Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 June 2021 | Story Xolisa Mnukwa | Photo Supplied
CUADS: Recognised for its efforts in human reconciliation within higher education spaces by creating and providing opportunities for students with disabilities to thrive academically.

In commemoration of Youth Month 2021, the South African government zooms in to uncover opportunities available to the South African youth, drawing more young people into the economy, and initiating various youth development and empowerment initiatives to support young people.

In line with this, the University of the Free State (UFS) Centre for Universal Access and Disability Support (CUADS) has established and implemented a number of technological and academic support measures to humanise the experiences of students with disabilities at the UFS, encouraging universal access and academic success for all students.  The ultimate aim is to have young people with disabilities employed in order to participate in the economy of South Africa.

CUADS continues the mission established when the department first opened: to become a higher-education institution support service recognised for its efforts in human reconciliation by creating and providing opportunities for students with disabilities to ultimately achieve academically, and to have an institutional culture of embracing and welcoming persons with disabilities on all three campuses of the UFS.

According to Martie Miranda, Assistant Director of CUADS and chair of the Higher and Further Education Disability Services Association, CUADS is monumental in its ability to accommodate the specific needs of students with sensory, physical, and learning disabilities, and has inspired other South African universities to enhance the qualities of their services by adapting their strategic visions to that of CUADS, which aims to operationalise and cater for the core needs of students through the UFS Integrated Transformation Plan (ITP), founded on the Strategic Policy Framework on Disability for the post-education and training sector. 

The UFS ITP assists in addressing physical barriers (accessibility to and within buildings, e.g., ramps, doorways, services, and information), attitudinal barriers (communication access, awareness and advocacy, integrated programmes to mix and learn between peers), and structural barriers (policies, flexible service delivery, and employment practices).

CUADS, in line with the UFS Division of Student Affairs (DSA), prioritises student success and plans to maintain continuous engagement with students (on an individual basis, but also per disability category) to continue the support needed to ensure student success.


News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept